The U.S. Supreme Court is scheduled to rule on the abortion and miscarriage treatment drug Mifepristone Friday after postponing the move two days. After conflicting decisions from two federal courts on if heavy restrictions or bans should be placed on the medication, the high court will now decide its fate. The loss of the drug has Madison doctors concerned for the future.